Trial NCT02049151

View at ClinicalTrials.gov 
Org. Study IDs: EMR 63325-021
Secondary IDs: 2013-003760-30

Last trial update was posted on 2017-08-23

MeSH Interventions

Cyclophosphamide

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC

Limitations And Caveats

Sponsor discontinued development of tecemotide (L-BLP25) in NSCLC, hence the study was terminated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID